Innovative therapeutics

Investors

NASDAQBMRN
FormDescriptionDateFormat
DEFR14ADEFR14AJun 6, 2005View HTMLDownload DOCDownload PDFDownload XLS
DEFA14AAdditional proxy soliciting materials - definitiveJun 1, 2005View HTMLDownload DOCDownload PDFDownload XLS
DEFC14ADefinitive proxy statement in connection with contested solicitationsMay 23, 2005View HTMLDownload DOCDownload PDFDownload XLS
DEFA14AAdditional proxy soliciting materials - definitiveMay 23, 2005View HTMLDownload DOCDownload PDFDownload XLS
DEFC14ADefinitive proxy statement in connection with contested solicitationsMay 23, 2005View HTMLDownload DOCDownload PDFDownload XLS
PRER14AProxy soliciting materials. Revised preliminary materialMay 19, 2005View HTMLDownload DOCDownload PDFDownload XLS
PRRN14ANon-management revised preliminary proxy soliciting materialsMay 19, 2005View HTMLDownload DOCDownload PDFDownload XLS
PRRN14ANon-management revised preliminary proxy soliciting materialsMay 19, 2005View HTMLDownload DOCDownload PDFDownload XLS
PRRN14ANon-management revised preliminary proxy soliciting materialsMay 17, 2005View HTMLDownload DOCDownload PDFDownload XLS
PRER14AProxy soliciting materials. Revised preliminary materialMay 16, 2005View HTMLDownload DOCDownload PDFDownload XLS
PREC14APreliminary proxy statement containing contested solicitationsMay 4, 2005View HTMLDownload DOCDownload PDFDownload XLS
PRE 14AA preliminary proxy statement providing notification matters to be brought to a voteMay 2, 2005View HTMLDownload DOCDownload PDFDownload XLS
PRE 14AA preliminary proxy statement providing notification matters to be brought to a voteMay 2, 2005View HTMLDownload DOCDownload PDFDownload XLS
DFAN14AAdditional proxy soliciting materials filed by non-managementApr 22, 2005View HTMLDownload DOCDownload PDFDownload XLS
DFAN14AAdditional proxy soliciting materials filed by non-managementApr 18, 2005View HTMLDownload DOCDownload PDFDownload XLS
PREC14APreliminary proxy statement containing contested solicitationsApr 15, 2005View HTMLDownload DOCDownload PDFDownload XLS

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information